Heart Test Laboratories, Inc. Engages OfferBoard Securities for Capital Raise to Bring Next Gen EKG to Market
OfferBoard
Securities, LLC announces it has been retained by medical device
company Heart Test Laboratories, Inc. to provide investment banking
services and assist with raising capital to bring the next generation
EKG device (MyoVista) to market.
Heart Test
Labs mission is to provide accurate, affordable screening tools for the
early detection of heart disease, and the MyoVista is the culmination of
over 15 years of R&D and $15MM invested to date. OfferBoard
Securities, a national investment bank and broker-dealer, will assist
Heart Test Labs with raising $2 million in order to fund inventory,
working capital and support selling the MyoVista by early 2016.
“Heart disease is common and deadly but
treatable if detected early. Unfortunately we still live in a world
where most people find out about their condition through a heart attack
or worse death” said Heart Test Labs Chairman Andrew Simpson. “While
cardiologists have the tools for effective treatment of heart disease,”
continued Simpson, “the big diagnostic gap is identifying at an early
stage who should seek treatment. This is where the MyoVista comes into
play.”